A comparison of long-term post-thymectomy outcome of anti-AChR-positive, anti-AChR-negative and anti-MuSK-positive patients with non-thymomatous myasthenia gravis

Expert Opinion on Biological Therapy

Volumn 9, Issue 1, 2009, Pages 1-8

  Ponseti, José M ^a   Caritg, Norma ^a   Gamez, Josep ^a   López Cano, Manuel ^a   Vilallonga, Ramón ^a   Armengol, Manuel ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Acetylcholine receptor antibodies; Muscle specific kinase antibodies; Muscle weakness; Myasthenia gravis; Seronegative myasthenia gravis; Thymectomy

Indexed keywords

ANTIBODY; CHOLINERGIC RECEPTOR ANTIBODY; MUSCLE SPECIFIC KINASE ANTIBODY; UNCLASSIFIED DRUG; CHOLINERGIC RECEPTOR; MUSK PROTEIN, HUMAN; PROTEIN TYROSINE KINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ASSESSMENT; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; SCHOOL CHILD; SEROLOGY; THYMECTOMY; THYMUS; COMPARATIVE STUDY; IMMUNOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; RETROSPECTIVE STUDIES; THYMECTOMY;

EID: 58149389093     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712590802588831     Document Type: Article

References (28)

1. Vincent A, Li Z, Hart A, et al. Seronegative myasthenia gravis. Evidence for plasma factor(s) interfering with acetylcholine receptor function. Ann NY Acad Sci 1993 ; 681 : 529-38 •• Landmark study of seronegative MG.
2. Hoch W, Mc Conville J, Helms S, et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001 ; 7 : 365-368 (Pubitemid 32224355)
3. De Chiara TM, Bowen DC, Valenzuela DM, et al. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 1996 ; 85 : 501-512 (Pubitemid 26157189)
4. Plested CP, Tang T, Spreadbury I, et al. AChR phosphorylation and indirect inhibition of AChR function in seronegative MG. Neurology 2002 ; 59 : 1682-1688 (Pubitemid 35424446)
5. Juel VC, Massey JM. Myasthenia gravis. Orphanet J Rare Dis 2007 ; 2 : 44. Doi:10.1186/1750-1172-2-44
6. Leite MI, Ströbel P, Jones M, et al. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann Neurol 2005 ; 57 : 444-448 (Pubitemid 40343969)
7. Lavrnic D, Losen M, Vujic A, et al. The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiatry 2005 ; 76 : 1099-1102 (Pubitemid 41081284)
8. Lauriola L, Ranelletti F, Maggiano N, et al. Thymus changes in anti-MuSK-positive and-negative myasthenia gravis. Neurology 2005 ; 64 : 563-568 (Pubitemid 40189877)
9. Jaretzki A 3rd, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards [Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America]. Neurology 2000 ; 55 : 16-23 •• Important consensus recommendations for uniform assessment of clinical status of MG patients.
10. Ponseti JM, Gamez J, Vilallonga R, et al. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis. Eur J Cardiothorac Surg 2008 ; 34 : 1062-1067
11. Ponseti JM, Azem J, Fort JM, et al. Experience with starting tacrolimus postoperatively after extended thymectomy in patients with myasthenia gravis. Curr Med Res Opin 2006 ; 22 : 885-895 (Pubitemid 43875556)
12. Ponseti JM, Gamez J, Azem J, et al. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, con-controlled study. Curr Med Res Opin 2007 ; 23 : 1269-1278 (Pubitemid 46998436)
13. Oosterhuis HJ. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry 1989 ; 52 : 1121-1127 (Pubitemid 19255673)
14. Grob D, Brunner NG, Namba T. The natural course of myasthenia gravis and effect of therapeutic measures. Ann NY Acad Sci 1981 ; 377 : 652-669
15. Evoli A, Tonali PA, Padua L, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003 ; 126 : 2304-11 • Important study on anti-MuSK antibodies in seronegative MG. (Pubitemid 37432373)
16. Sanders DB, El-Salem K, Massey JM, et al. Clinical aspects of MuSK antibody positive seronegative MG. Neurology 2003 ; 60 : 1978-1980 (Pubitemid 36736017)
17. Kostera-Pruszczyk A, Kaminska A, Dutkiewicz M, et al. MuSK-positive myasthenia gravis is rare in the Polish population. Eur J Neurol 2008 ; 15 : 720-724 (Pubitemid 351814419)
18. Vincent A, Bowen J, Newsom-Davis J, McConville J. Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets. Lancet Neurol 2003 ; 2 : 99-106 (Pubitemid 37443330)
19. Illa I, Díaz-Manera JA, Juárez C, et al. Seronegative" myasthenia gravis and antiMuSK positive antibodies: description of Spanish series. [Article in Spanish]. Med Clin (Barc) 2005 ; 125 : 100-102
20. Deymeer F, Gungor-Tuncer O, Yilmaz V, et al. Clinical comparison of anti-MuSK-vs anti-AChR-positive and seronegative myasthenia gravis. Neurology 2007 ; 68 : 609-611 (Pubitemid 46303613)
21. Padua L, Tonali P, Aprile I, et al. Seronegative myasthenia gravis: comparison of neurophysiological picture in MuSK+ and MuSK-patients. Eur J Neurol 2006 ; 13 : 273-276
22. Shibata-Hamaguchi A, Samuraki M, Furui E, et al. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis. Acta Neurol Scand 2007 ; 116 : 406-408 (Pubitemid 350045493)
23. Takahashi H, Kawaguchi N, Nemoto Y, Hattori T. High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis. J Neurol Sci 2006 ; 247 : 239-241 (Pubitemid 44301266)
24. Hain B, Jordan K, Deschauer M, Zierz S. Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab. Muscle Nerve 2006 ; 33 : 575-580
25. Ponseti JM, Gamez J, Azem J, et al. Tacrolimus for myasthenia gravis: a clinical study of 212 patients. Ann NY Acad Sci 2008 ; 1132 : 254-63 • A large clinical series of MG patients treated with tacrolimus.
26. Drachman DB, Jones RJ, Brodsky RA. Treatment of refractory myasthenia: "rebooting" with high-dose cyclophosphamide. Ann Neurol 2003 ; 53 : 29-34 • This study adds information on the treatment of refractory MG.
27. Yuan HK, Huang BS, Kung SY, Kao KP. The effectiveness of thymectomy on seronegative generalized myasthenia gravis: comparing with seropositive cases. Acta Neurol Scand 2007 ; 115 : 181-184 (Pubitemid 46219211)
28. Newsom-Davis J, Cutter G, Wolfe GI, et al. Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone. NY Acad Sci USA 2008 ; 1132 : 344-7 •• First ongoing randomized study to assess the role of thymectomy in MG.